Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Invested Capital: 2019-2021

Historic Return on Invested Capital for Neurocrine Biosciences (NBIX) over the last 2 years, with Sep 2021 value amounting to 0.05%.

  • Neurocrine Biosciences' Return on Invested Capital fell 5.00% to 0.05% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.05%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of 0.05% for FY2019, which is 2.00% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Return on Invested Capital stood at 0.05%, which was down 45.07% from 0.09% recorded in Q2 2021.
  • Neurocrine Biosciences' Return on Invested Capital's 5-year high stood at 0.21% during Q2 2020, with a 5-year trough of 0.05% in Q3 2021.
  • In the last 3 years, Neurocrine Biosciences' Return on Invested Capital had a median value of 0.10% in 2020 and averaged 0.11%.
  • Data for Neurocrine Biosciences' Return on Invested Capital shows a maximum YoY decreased of 12bps (in 2021) over the last 5 years.
  • Over the past 3 years, Neurocrine Biosciences' Return on Invested Capital (Quarterly) stood at 0.05% in 2019, then reached 0.10% in 2020, then decreased by 5bps to 0.05% in 2021.
  • Its Return on Invested Capital stands at 0.05% for Q3 2021, versus 0.09% for Q2 2021 and 0.10% for Q1 2021.